VandenbergheNDebouverieMAnxionnatRClavelouPBoulySWeberM.Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol. 2003;10(1):63–66. doi:10.1046/j.1468-1331.2003.00513.x.
3.
SahraianMAMotamediMAzimiARMoghimiB.Androgen-induced cerebral venous sinus thrombosis in a young bodybuilder: case report. BMC Neurol. 2004;4(1):22. doi:10.1186/1471-2377-4-22.
4.
ShiozawaZYamadaHMabuchiC, et al. Superior sagittal sinus thrombosis associated with androgen therapy for hypoplastic anemia. Ann Neurol. 1982;12:578–580. doi:10.1002/ana.410120613.
5.
JaillardASHommelMMallaretM.Venous sinus thrombosis associated with androgens in a healthy young man. Stroke. 1994;25:212–213. doi:10.1161/01.STR.25.1.212.
6.
HashmiAKimPAhmadSWFaucheuxJGandikalN.Superior sagittal venous sinus thrombosis in a patient with illicit testosterone use. Cureus. 2019;11(8):e5491. doi:10.7759/cureus.5491.
7.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245. doi:10.1038/clpt.1981.154.
8.
FayyazMAbbasFKashifT.The role of warfarin and rivaroxaban in the treatment of cerebral venous thrombosis. Cureus. 2019;11(5):e4589. doi:10.7759/cureus.4589.
9.
YggeJBrodySKorsan-BengtsenKNilssonL.Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study. Am J Obstet Gynecol. 1967;21:197–201. doi:10.1016/s0002-9378(16)34145-x.
10.
FerenchickGSHirokawaSMammenEFSchwartzKA.Anabolic-androgenic steroid abuse in weight lifters: evidence for activation of the hemostatic system. Am J Hematol. 1995;49:282–288. doi:10.1002/ajh.2830490405.